CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
Abstract
Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United States. HCV is transmitted primarily through parenteral exposures to infectious blood or body fluids that contain blood, most commonly through injection drug use. No vaccine against hepatitis C exists and no effective pre- or postexposure prophylaxis is available. More than half of persons who become infected with HCV will develop chronic infection. Direct-acting antiviral treatment can result in a virologic cure in most persons with 8-12 weeks of all-oral medication regimens. This report augments (i.e., updates and summarizes) previously published recommendations from CDC regarding testing for HCV infection in the…
Citation impact
- FWCI
- 43.18
- Percentile
- 100%
- References
- 100
Authors
5- SSSarah SchillieCorresponding
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
- CWCarolyn Wester
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
- MOMelissa Osborne
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
- LGLaura G. Wesolowski
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
- ABA. Blythe Ryerson
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
Topics & keywords
- Medicine
- Hepatitis C virus
- Hepatitis C
- Hepatitis
- Pregnancy
- Internal medicine
- Immunology
- Virus
- Good health and well-being